| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4f16e71d2cc81c549e81470d725e224
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e937fb076d031fdec51d70c299a0f415 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2013-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67e33cf3a02b3161f518b239e590e18f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f44e03b2ca25f4280fab22765421967
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84e2d91bd3147666a449696caa2fb475 |
| publicationDate |
2017-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9751923-B2 |
| titleOfInvention |
Administration of DKK1 muteins to treat fibrosis |
| abstract |
The present disclosure provides molecules, compositions and methods for treating scarring in organs. The molecules, compositions and methods treat scarring by modulating the WNT, platelet-derived growth factor receptor (PDGFR), transforming growth factor-beta (TGF3) and/or connective-tissue growth factor (CTGF) signaling pathways. |
| priorityDate |
2012-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |